Treatment of diabetes by at least one epidermal growth...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 3/10 (2006.01) C07K 16/28 (2006.01) C07K 16/32 (2006.01)

Patent

CA 2671585

The present invention relates to the use of at least one epidermal growth factor receptor specific antibody or a derivative thereof for the manufacture of a medicament for the treatment of diabetes, in particular of the advanced insulin-dependent stage of diabetes mellitus Type 1 and 2 in humans as well as in animals.

L'invention concerne l'utilisation d'au moins un anticorps spécifique du récepteur du facteur de croissance épidermique ou un dérivé de ce dernier dans la fabrication d'un médicament destiné au traitement du diabète, en particulier du stade avancé, dépendant de l'insuline, du diabète sucré de type 1 et de type 2 chez les humains et chez les animaux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of diabetes by at least one epidermal growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of diabetes by at least one epidermal growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diabetes by at least one epidermal growth... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1576919

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.